| |
| |
|
| Insider
Information: |
Loerop James |
| Relationship: |
Chief Business Officer |
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
39,609 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$200,546 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,609 |
|
|
| Total
Value |
$200,546 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anika Therapeutics Inc |
ANIK |
EVP Business Development |
2021-07-08 |
5,592 |
2020-07-08 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Chief Business Officer |
2024-02-01 |
34,017 |
2023-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Business Officer |
• – – |
2024-02-01 |
4 |
D |
$1.20 |
$7,705 |
D/D |
(6,421) |
34,017 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Business Officer |
• – – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
36,585 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Business Officer |
• – – |
2023-08-28 |
4 |
B |
$6.80 |
$99,959 |
D/D |
14,705 |
21,688 |
2.74 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Business Officer |
• – – |
2023-02-08 |
4 |
S |
$13.89 |
$59,272 |
D/D |
(4,267) |
6,983 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Business Officer |
• – – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
11,250 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
EVP Business Development |
• – – |
2021-07-08 |
4 |
D |
$43.24 |
$31,608 |
D/D |
(731) |
5,592 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
EVP Business Development |
• – – |
2021-07-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
6,323 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
EVP Business Development |
• – – |
2021-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,567 |
3,323 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
EVP Business Development |
• – – |
2020-07-09 |
4 |
S |
$35.15 |
$43,727 |
D/D |
(1,244) |
1,756 |
0 |
% |
|
| ANIK |
Anika Therapeutics Inc |
EVP Business Development |
• – – |
2020-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
